Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The financial cost and consequences of having cancer in Ireland Collaborative Project between the Irish Cancer Society and the National Cancer Registry Ireland Funded by the Irish Cancer Society Aileen Timmons, L Sharp, A-E Carsin, N Donnelly, J Kelly, J McCormack, N Ni Chonghaile, C O’Callaghan, E O’Donnell, O Ryan, H Comber Population-based cancer research in Ireland Meeting, Dublin, August 2009 Background • Economics of cancer poorly understood even internationally. • Areas of cost and costs themselves – likely to be somewhat specific to particular health and social care system. • No good “off-the-shelf” questionnaires or other tools to assess costs available. • Lack of evidence-based data for Ireland. Methods Breast, lung, and prostate cancer. Phase 1: Qualitative methods – Semi-structured interviews Phase 2: Quantitative methods – Postal questionnaire survey Methods Breast, lung, and prostate cancer. Phase 1: Qualitative methods – Semi-structured interviews 1. In-depth interviews with key informants: Hospital-based oncology social workers. 2. In-depth interviews with patients (who had additional costs / financial difficulties as a result of their cancer diagnosis - “financial difficulties” was selfdefined). Phase 2: Quantitative methods – Postal questionnaire survey Methods Breast, lung, and prostate cancer. Phase 1: Qualitative methods – Semi-structured interviews Phase 2: Quantitative methods – Postal questionnaire survey Large-scale quantitative survey of patients throughout Ireland. Aim to quantify the financial burden: How many affected? Who worst affected? How much additional spending? Etc… Methods Breast, lung, and prostate cancer. Phase 1: Qualitative methods – Semi-structured interviews Provides detailed informative data. Valuable first step in the development of instruments to quantify the financial impact of cancer. Phase 2: Quantitative methods – Postal questionnaire survey A quantitative survey instrument developed. Piloted and administered to patients with cancer throughout Ireland. Quantitative Survey Methods Socio-demographic information Savings & Borrowing Household spending • • • • • • Work & Employment Postal Questionnaire Health related costs Overall financial situation Patients with breast, lung or prostate cancer. Identified from NCRI database. Within 6 months and 2 years of diagnosis. 17 hospitals across country (Incl. 3 private hospitals). After exclusions, n=1373. Survey done June-Sept 2008. Survey participants Responders n=740 (54%) Cancer site % Employment status % breast 67% paid employment 37% lung 3% self-employed 12% prostate 29% not in paid employment 24% retired/other 24% Respondents patient 93% proxy (family member) 7% Age at diagnosis <50 25% 50-59 30% 60-69 26% 70+ 18% Marital status Other Children/adults dependents 43% Medical card at diagnosis 36% Social welfare/HSE payments 24% at diagnosis married/living as married 72% living alone 26% Health insurance at diagnosis 63% Treatment-related costs 71% Travelling Expenses Average (median) amount = €360 1 in 4 paid > €788 52% Paid for Parking Average (median) amount = €75 1 in 4 paid > €160 Visits to GP 36% Health-Related Costs Visits to Consultants 45% Complementary Physiotherapy Therapies 15% Other Therapies 9% (e.g. occupational therapy) Counselling 2% 6% Visits to GP 36% €250* Health-Related Costs Visits to Consultants 45% €465* Complementary Physiotherapy Therapies 15% Other Therapies 9% €320* (e.g. occupational therapy) Counselling 2% €400* 6% €360* *Average (median) amount spent Over-the-counter Prescription Medications 39% Dietary supplements Medications 29% 13% (not covered on medical card or insurance) Visits to GP 36% €250* Health-Related Costs Visits to Consultants 45% €465* Complementary Physiotherapy Therapies 15% Other Therapies 9% €320* (e.g. occupational therapy) Counselling 2% €400* 6% €360* *Average (median) amount spent Lymph Drainage 5% €140* Health-Related Costs Breast Cancer Wigs & Hairpieces 40% €400* *Average (median) amount spent Lymph Drainage 5% €140* Health-Related Costs Breast Cancer 1 in 5 Paid >€500 Wigs & Hairpieces 40% €400* *Average (median) amount spent Stayed the same 41% respondents Spending on household bills since cancer diagnosis Increased 59% respondents Increased Food Bills 29% Increased Telephone bills 42% Increased Heating bills 44% Stayed the same 49% respondents Decreased a little 2% Increased a little 34% Changes in average day-to-day spending because of cancer diagnosis Decreased a lot 1% Increased a lot 13% Stayed the same 49% respondents Decreased a little 2% Increased a little 34% Changes in average day-to-day spending because of cancer diagnosis Decreased a lot 1% 47% respondents Increased a lot 13% Spending reduced or cut since cancer diagnosis Regular items (e.g. new clothes, take-away meals, etc.) 21% Leisure activities 12% Holidays 20% Mortgage (n=206) 43% more difficult Ability to pay mortgage or personal loans since cancer diagnosis Loans (n=203) 40% more difficult Didn’t use savings 44% Need to use savings since cancer diagnosis Used some savings Used all savings 49% 6% Didn’t use savings 44% Need to use savings since cancer diagnosis Used some savings Used all savings 49% 6% 55% respondents Didn’t use savings 44% Need to use savings since cancer diagnosis Used some savings Used all savings 49% 6% 55% respondents Frequency higher among: • • • • • younger age (<50=78%; 50-59=61%) working (paid employment=67%; self-employed=62%) no health insurance (69%) with dependents (63%) lone parents (92%) Need to borrow since cancer diagnosis 11% Bank/Credit Union Credit cards 8% 2% Family/Friends 5% Employment No. working at diagnosis = 364 (49%) Took time off work 85% Finances affected decision Received sick pay from employer 49% 16% Family members changed working pattern 16% Income decreased 58% Medical cards & social welfare payments Claimed new social welfare payment since cancer diagnosis Got medical card since diagnosis 61% 24% Experience of finding out about and applying for new social welfare/HSE payments: Very easy Quite easy Quite difficult Very difficult Getting information Application process* 30% 47% 14% 9% 27% 52% 14% 7% * % of those who applied for new payments Medical cards & social welfare payments Claimed new social welfare payment since cancer diagnosis Got medical card since diagnosis 61% 24% Experience of finding out about and applying for new social welfare/HSE payments: Very easy Quite easy Quite difficult Very difficult Getting information Application process* 30% 47% 14% 9% 27% 52% 14% 7% 1 in 5 * % of those who applied for new payments Stayed the same 59% Household income since cancer diagnosis Decreased 11% Increased 30% Stayed the same 59% Household income since cancer diagnosis Decreased 11% Increased 30% Frequency higher among: • • • • woman (35%) younger age (<50=54%; 50-59=39%) working (paid employment=52%; self-employed=47%) with dependents (43%) No more or less difficult 44% Cancer diagnosis has made household’s ability to make ends meet…… Less difficult 8% A little more difficult 25% More difficult 44% More difficult 15% Much more difficult 8% No more or less difficult 44% Cancer diagnosis has made household’s ability to make ends meet…… Less difficult 8% Frequency higher among: • younger age (<50 = 69%; 50-59 = 58%) • working at diagnosis (61%) • with dependents (60%) • lone parents (79%) A little more difficult 25% More difficult 44% More difficult 15% Much more difficult 8% No more or less concerned 37% Feelings about household’s financial situation since cancer diagnosis…. Less concerned 31% More concerned 32% No more or less concerned 37% Feelings about household’s financial situation since cancer diagnosis…. Less concerned 31% A little more concerned More concerned 32% 15% Much more concerned Frequency didn’t vary by socio-economic variables very concerned 5% 8% Psychosocial impact Household ability to make ends meet since cancer diagnosis Less difficult No more or less difficult More difficult Psychosocial impact Household ability to make ends meet since cancer diagnosis Less difficult 33% No more or less difficult 24% Depression More difficult 51% Psychosocial impact Household ability to make ends meet since cancer diagnosis Less difficult No more or less difficult More difficult Depression 33% 24% 8% 6% 51% 27% Severe depression Psychosocial impact Feelings about household financial situation since cancer diagnosis Less concerned No more or less concerned More concerned Depression 39% 23% 15% 7% 52% 30% Severe depression Psychosocial impact Household ability to make ends meet since cancer diagnosis Less difficult No more or less difficult More difficult Stressed 50% Anxious 44% Psychosocial impact Feelings about household financial situation since cancer diagnosis Less concerned No more or less concerned More concerned Stressed 50% Anxious 44% Conclusions • Cancer can have a significant adverse financial impact for patients and their families in Ireland • Most patients/families incur some additional costs; for some patients/families, these are substantial • Exacerbated by lost income and limited sick-pay • Some groups of patients appear particularly vulnerable (e.g. younger age, working, dependents) • Wide-ranging consequences - including using savings, borrowing money, reduced spending on “extras” and increased concerns, and adverse psychosocial effects (depression, stress, anxiety) Implications Target Areas Treatment-related travel costs Other health-related costs Household expenses Accessing social welfare/HSE payments and medical cards Sick-pay entitlement Burden on the family Health and social services Patient support groups Employers Thank you to: • The Irish Cancer Society for funding this work. • Those who were interviewed and completed questionnaires: •Oncology Social Workers. •Patients. •Family Members. • Health professionals who helped to recruit patients: •Oncology Social Workers. •Clinical Nurse Specialists/Oncology Nurses. •Consultants. •Cancer Support Groups. • Colleagues at NCRI: L Sharp, H Comber, A-E Carsin (statistical analysis), C O’Callaghan (administration), F Dwane and T Kelleher (data extraction from NCRI database), F Drummond and J Murphy (double coding of interview transcripts), and other colleagues at the National Cancer Registry who helped with IT and administration. • Steering Committee: L Sharp, N Donnelly, J Kelly, J McCormack, N Ni Chonghaile, E O’Donnell, O Ryan, H Comber • For further information contact: [email protected]